IS5062A - Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns - Google Patents

Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns

Info

Publication number
IS5062A
IS5062A IS5062A IS5062A IS5062A IS 5062 A IS5062 A IS 5062A IS 5062 A IS5062 A IS 5062A IS 5062 A IS5062 A IS 5062A IS 5062 A IS5062 A IS 5062A
Authority
IS
Iceland
Prior art keywords
preparations containing
medicinal preparations
sulfonylindoline
derivatives
sulfonylindoline derivatives
Prior art date
Application number
IS5062A
Other languages
English (en)
Icelandic (is)
Inventor
Gautier Jean-Claude
John Fuller Simon
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of IS5062A publication Critical patent/IS5062A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
IS5062A 1996-12-05 1999-06-01 Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns IS5062A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614957A FR2756736B1 (fr) 1996-12-05 1996-12-05 Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline
PCT/FR1997/002210 WO1998024430A1 (fr) 1996-12-05 1997-12-04 Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline

Publications (1)

Publication Number Publication Date
IS5062A true IS5062A (is) 1999-06-01

Family

ID=9498376

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5062A IS5062A (is) 1996-12-05 1999-06-01 Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns

Country Status (25)

Country Link
EP (1) EP0941090A1 (ko)
JP (1) JP2000507618A (ko)
KR (1) KR20000069308A (ko)
CN (1) CN1239887A (ko)
AR (1) AR009651A1 (ko)
AU (1) AU716575B2 (ko)
BR (1) BR9712406A (ko)
CA (1) CA2273990A1 (ko)
CO (1) CO4910129A1 (ko)
DZ (1) DZ2362A1 (ko)
EE (1) EE9900206A (ko)
FR (1) FR2756736B1 (ko)
HU (1) HUP0001386A3 (ko)
ID (1) ID23373A (ko)
IL (1) IL129936A0 (ko)
IS (1) IS5062A (ko)
MY (1) MY132819A (ko)
NO (1) NO992724D0 (ko)
NZ (1) NZ335750A (ko)
RU (1) RU2174394C2 (ko)
SK (1) SK75599A3 (ko)
TR (1) TR199901702T2 (ko)
WO (1) WO1998024430A1 (ko)
YU (1) YU23099A (ko)
ZA (1) ZA9710919B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786486B3 (fr) * 1998-11-16 2000-12-08 Sanofi Sa Procede de preparation du (2s)-1-[(2r,3s)-5-chloro-3-(2- chlorophenyl)-1-(3,4-dimethoxy benzenesulfonyl)-3-hydroxy- 2,3-dihydro-1h-indole-2-carbonyl]pyrrolidine-2-carboxamide, de ses solvats et/ou hydrates
DE19913692A1 (de) * 1999-03-25 2000-09-28 Basf Ag Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
WO2001034119A2 (en) 1999-11-12 2001-05-17 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
FR2805992A1 (fr) * 2000-03-08 2001-09-14 Sanofi Synthelabo Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
ITMI20011338A1 (it) * 2001-06-26 2002-12-26 Farmatron Ltd Composizioni farmaceutiche orali a rilascio immediato del principio attivo
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
UA119324C2 (uk) * 2013-04-02 2019-06-10 Теміс Медікер Лімітед Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
KR102139339B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물
KR102139338B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
CN1239887A (zh) 1999-12-29
NO992724L (no) 1999-06-04
KR20000069308A (ko) 2000-11-25
FR2756736A1 (fr) 1998-06-12
IL129936A0 (en) 2000-02-29
ZA9710919B (en) 1999-06-04
EE9900206A (et) 1999-12-15
TR199901702T2 (en) 1999-09-21
CO4910129A1 (es) 2000-04-24
JP2000507618A (ja) 2000-06-20
SK75599A3 (en) 2000-08-14
NO992724D0 (no) 1999-06-04
AR009651A1 (es) 2000-04-26
MY132819A (en) 2007-10-31
WO1998024430A1 (fr) 1998-06-11
DZ2362A1 (fr) 2002-12-28
EP0941090A1 (fr) 1999-09-15
HUP0001386A2 (hu) 2001-04-28
CA2273990A1 (fr) 1998-06-11
AU716575B2 (en) 2000-03-02
BR9712406A (pt) 1999-08-31
HUP0001386A3 (en) 2002-03-28
NZ335750A (en) 2001-06-29
YU23099A (en) 1999-11-22
ID23373A (id) 2000-04-20
RU2174394C2 (ru) 2001-10-10
AU5326298A (en) 1998-06-29
FR2756736B1 (fr) 1999-03-05

Similar Documents

Publication Publication Date Title
ATE236617T1 (de) Aerosol-arzneiformulierungen
NO974618D0 (no) Farmasöytiske preparater for intranasal administrasjon
ATE304351T1 (de) Arzneizubereitungen enthaltend kannabinoide
DE69518331T2 (de) Orale zubereitungen
DE69708327D1 (de) Pulverinhalator
DK0783302T3 (da) Lægemidler
IL131319A0 (en) 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
DE59707298D1 (de) Desodorierende zubereitungen
IS5062A (is) Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns
DE69700887D1 (de) Isoprenderivate
ID16781A (id) Formulasi-formulasi farmasi
DE69432149T2 (de) Orale Zubereitungen
DK0925273T3 (da) Farmaceutiske præparater indeholdende 4-oxo-butansyrer
ATE298576T1 (de) Arzneizubereitungen
ITMI941169A0 (it) Formulazioni farmaceutiche
DK0826679T3 (da) Naphthylforbindelser og -præparater
ID18698A (id) Komposisi farmasi
EE03511B1 (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
ATE237309T1 (de) Arzneizubereitungen
EP1142589A4 (en) MEDICAL COMPOSITIONS
FI951155A0 (fi) Farmaseuttinen valmiste
ITMI962628A0 (it) Composizione farmaceutica
DE69523817T2 (de) Desodorisierende Präparate